By working collaboratively across the ecosystem, we help ensure that consumers have access to safe and effective solutions and medications. The End of the GLP-1 Shortage In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Shintani T., Yamada T., Hayashi N., Iida T., Nagata Y., Ozaki N., Toyoda Y
The Scale of the Problem Global meta-analysis data puts PCOS prevalence at 9.2% of reproductive-age as of 2021 (65.77 million women)
Some adverse clinical effects were observed, such as diarrhea, decreased appetite, nausea, and fatigue
Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes